EURONEXT:ALVIO
Valerio Therapeutics Société anonyme
- Stock
Last Close
0.10
26/07 15:35
Market Cap
15.49M
Beta: 1.63
Volume Today
22.25K
Avg: 76.64K
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.94K - | 34.16K 1,061.05% | 85.59K 150.56% | 145K 69.42% | 107K 26.21% | 38.50K 64.02% | 55.50K 44.16% | 32K 42.34% | |||
average payables | 4.17M - | 5.62M 34.55% | 6.52M 16.07% | 7.80M 19.71% | 7.60M 2.60% | 5.05M 33.55% | 3.91M 22.61% | 3.22M 17.69% | 2.80M 13.06% | 3.14M 12.28% | |
average receivables | 2.56M - | 2.56M 0% | 3.90M 52.57% | 7.62M 95.41% | 3.72M 51.17% | 2.76M - | 2.76M 0% | ||||
book value per share | 0.36 - | 2.99 736.57% | 2.52 15.72% | 1.99 21.12% | 0.98 50.81% | 0.85 13.36% | 0.24 71.50% | 0.40 65.53% | 0.37 6.53% | ||
capex per share | -0.00 - | -0.00 97.80% | -0.01 12,552.44% | -0.01 88.64% | -0.00 88.93% | -0.00 34.11% | -0.00 56.52% | -0.00 348.71% | -0.00 3.76% | ||
capex to depreciation | -13.37 - | -0.00 99.98% | -0.11 4,727.61% | -0.34 200.78% | -0.00 99.52% | -0.00 203.73% | -0.00 79.12% | 0.01 1,514.81% | -0.27 1,977.82% | 2.92 1,174.26% | |
capex to operating cash flow | 0.00 - | 0.00 92.14% | 0.01 4,127.11% | 0.03 187.33% | 0.00 92.57% | 0.00 73.79% | 0.00 15.45% | 0.03 653.26% | 0.02 36.26% | 0.05 218.70% | |
capex to revenue | -0.03 - | -0.00 99.71% | -0.07 80,133.27% | -0.12 72.27% | -0.01 94.45% | -0.01 7.40% | -0.01 17.44% | -0.07 1,005.06% | -0.03 48.93% | -0.34 888.28% | |
cash per share | 0.54 - | 1.40 157.69% | 0.83 40.95% | 0.62 25.42% | 0.28 54.70% | 0.21 24.98% | 0.08 61.83% | 0.20 149.44% | 0.20 1.47% | ||
days of inventory on hand | 4.34 - | 95.59 2,100.65% | 114.81 20.10% | 102.53 10.69% | 17.27 83.16% | 79.79 361.98% | 66.74 16.35% | ||||
days payables outstanding | 6.29K - | 9.79K 55.58% | 6.89K 29.63% | 5.15K 25.23% | 3.43K 33.45% | 7.04K 105.22% | 3.83K 45.58% | 519.12 86.44% | 2.81K 441.09% | 2.45K 12.81% | |
days sales outstanding | 1.27K - | 817.42 - | 613.83 24.91% | 469.10 - | |||||||
debt to assets | 0.01 - | 0.01 179.71% | 0.01 57.58% | 0.01 2.59% | 0.01 46.65% | 0.11 1,178.47% | 0.22 97.63% | 0.13 38.86% | 0.28 106.80% | 0.23 15.85% | |
debt to equity | 0.01 - | 0.02 46.11% | 0.01 57.21% | 0.01 3.02% | 0.01 72.66% | 0.16 1,037.75% | 0.48 210.42% | 0.22 55.25% | 0.45 107.98% | 0.45 1.07% | |
dividend yield | 0.22 - | 0.08 63.35% | |||||||||
earnings yield | -2.73 - | -0.70 74.37% | -1.76 152.11% | -1.77 0.67% | -4.29 141.79% | -0.65 84.86% | -1.75 170.04% | 0.06 103.17% | -0.25 549.17% | ||
enterprise value | -5.62M - | -44.58M 693.66% | -17.40M 60.97% | -11.05M 36.49% | -369.23K 96.66% | 10.27M 2,880.41% | 21.81M 112.45% | 11.36M 47.93% | 20.69M 82.22% | -4.50M 121.74% | |
enterprise value over ebitda | 0.38 - | -12.94 3,508.67% | 0.96 107.39% | 0.56 41.66% | 0.01 97.40% | -10.84 74,956.68% | 2.96 127.28% | -1.39 146.94% | -4.23 204.41% | 0.26 106.23% | |
ev to operating cash flow | 0.40 - | 5.77 1,348.18% | 0.75 86.96% | 0.63 16.63% | 0.01 97.92% | -0.91 7,079.65% | -2.83 210.88% | -2.43 14.31% | -2.41 0.56% | 0.48 119.73% | |
ev to sales | -3.83 - | -2.02 47.28% | -5.00 147.49% | -2.50 50.01% | -0.04 98.44% | 1.68 4,413.33% | 5.09 203.56% | 6.39 25.72% | 5.09 20.33% | -3.12 161.19% | |
free cash flow per share | -0.68 - | -0.19 72.13% | -0.57 202.46% | -0.38 33.04% | -0.56 44.89% | -0.21 62.02% | -0.11 48.61% | -0.07 39.12% | -0.10 49.61% | ||
free cash flow yield | -2.52 - | -0.70 72.13% | -2.12 202.46% | -1.42 33.04% | -2.06 44.89% | -0.78 62.02% | -0.40 48.61% | -0.24 39.12% | -0.37 49.61% | ||
graham net net | 0.23 - | 0.67 185.94% | 0.32 51.32% | 0.08 74.62% | -0.27 430.56% | -0.12 55.03% | -0.15 20.91% | -0.04 72.64% | -0.03 37.54% | ||
graham number | 2.43 - | 3.56 46.44% | 5.19 45.77% | 4.63 10.89% | 5.05 9.06% | 1.83 63.78% | 1.60 12.27% | 0.37 77.11% | 0.75 104.90% | ||
income quality | 0.92 - | 1.00 9.06% | 1.19 18.72% | 0.78 34.78% | 0.48 38.36% | 1.20 150.36% | 0.23 80.96% | -4.30 1,981.87% | 1.44 133.61% | 0.48 66.57% | |
intangibles to total assets | 0.00 - | 0.58 44,949.45% | 0.67 15.52% | 0.70 4.32% | 0.61 12.66% | 0.61 0.16% | 0.62 1.79% | 0.44 28.87% | 0.39 12.37% | 0.48 24.36% | |
interest coverage | -53.74 - | -0.19 99.64% | -18.40 9,347.20% | -53.02 188.08% | -17.16 67.63% | -15.09 12.11% | -9.44 37.39% | -8.15 13.73% | -3.29 59.61% | -7.82 137.56% | |
interest debt per share | 0.02 - | 0.13 620.82% | 0.05 62.73% | 0.02 48.97% | 0.04 41.40% | 0.15 327.71% | 0.13 13.22% | 0.10 24.08% | 0.19 87.93% | ||
inventory turnover | 84.03 - | 3.82 95.46% | 3.18 16.74% | 3.56 11.97% | 21.13 493.67% | 4.57 78.35% | 5.47 19.55% | ||||
invested capital | 0.01 - | 0.02 46.11% | 0.01 57.21% | 0.01 3.02% | 0.01 72.66% | 0.16 1,037.75% | 0.48 210.42% | 0.22 55.25% | 0.45 107.98% | 0.45 1.07% | |
market cap | 5.62M - | 11.02M 96.03% | 11.02M 0% | 12.79M 16.03% | 13.78M 7.76% | 14.48M 5.07% | 19.24M 32.89% | 19.62M 2.00% | 23.82M 21.38% | ||
net current asset value | 6.14M - | 32.92M 436.34% | 15.26M 53.65% | 5.86M 61.62% | 2.66M 54.62% | 2.53M 4.89% | -9.15M 461.87% | 5.71M 162.39% | 10.01M 75.43% | -237K 102.37% | |
net debt to ebitda | 0.76 - | -16.13 2,224.79% | 1.56 109.68% | 1.20 22.96% | 0.55 53.89% | 4.45 701.20% | 0.35 92.15% | 1.01 189.64% | 0.64 36.88% | 0.26 58.72% | |
net income per share | -0.74 - | -0.19 74.37% | -0.48 152.11% | -0.48 0.67% | -1.16 141.79% | -0.18 84.86% | -0.47 170.04% | 0.01 103.17% | -0.07 549.17% | ||
operating cash flow per share | -0.68 - | -0.19 72.04% | -0.57 199.32% | -0.37 34.35% | -0.55 49.03% | -0.21 62.09% | -0.11 48.57% | -0.06 40.43% | -0.10 50.97% | ||
payables turnover | 0.06 - | 0.04 35.72% | 0.05 42.11% | 0.07 33.74% | 0.11 50.26% | 0.05 51.27% | 0.10 83.76% | 0.70 637.67% | 0.13 81.52% | 0.15 14.69% | |
receivables turnover | 0.29 - | 0.45 - | 0.59 33.17% | 0.78 - | |||||||
research and ddevelopement to revenue | 0.44 - | 3.64 736.21% | 3.18 12.66% | 1.62 49.17% | 0.80 50.26% | 1.36 69.40% | 1.19 12.89% | 0.75 36.63% | 5.46 625.68% | ||
return on tangible assets | -0.86 - | -0.12 86.10% | -0.45 276.79% | -0.60 32.16% | -1.93 223.26% | -0.38 80.31% | -2.36 520.51% | 0.04 101.77% | -0.18 535.25% | -0.88 379.49% | |
revenue per share | 0.07 - | 0.54 667.98% | 0.09 84.23% | 0.09 9.50% | 0.19 99.37% | 0.11 38.65% | 0.06 47.34% | 0.02 59.40% | 0.05 88.44% | ||
roe | -2.06 - | -0.06 96.94% | -0.19 199.13% | -0.24 27.62% | -1.18 391.55% | -0.21 82.52% | -1.96 847.40% | 0.04 101.91% | -0.18 580.54% | -0.88 387.39% | |
roic | -2.14 - | -0.01 99.68% | -0.19 2,673.43% | -0.25 31.23% | -0.34 33.83% | -0.25 25.07% | -0.33 30.60% | -0.12 62.57% | -0.11 6.99% | -0.52 356.11% | |
sales general and administrative to revenue | 7.30 - | 0.93 - | 0.69 25.93% | 1.36 97.03% | 0.58 57.72% | 1.83 217.26% | |||||
shareholders equity per share | 0.36 - | 2.99 736.57% | 2.52 15.72% | 1.99 21.12% | 0.98 50.81% | 0.85 13.36% | 0.24 71.50% | 0.40 65.53% | 0.37 6.53% | ||
stock based compensation to revenue | 0.20 - | 0.03 83.05% | 0.11 218.83% | 0.11 1.46% | 0.10 5.37% | 0.15 46.74% | 0.10 32.02% | 0.04 56.75% | 0.06 23.97% | 0.50 809.84% | |
tangible asset value | 7.41M - | 34.04M 359.06% | 16.43M 51.73% | 6.88M 58.15% | 2.34M 65.98% | 6.83M 191.96% | -6.16M 190.22% | 8.50M 238.00% | 12.41M 45.98% | 1.54M 87.60% | |
tangible book value per share | 0.36 - | 0.83 134.18% | 0.40 51.73% | 0.15 63.93% | 0.05 68.43% | 0.13 177.88% | -0.09 167.89% | 0.12 235.29% | 0.14 20.27% | ||
working capital | 9.62M - | 50.03M 419.78% | 31.09M 37.85% | 24.45M 21.35% | 12.02M 50.86% | 11.98M 0.27% | 5.08M 57.56% | 17.13M 236.87% | 23.07M 34.68% | 13.43M 41.79% |
All numbers in EUR (except ratios and percentages)